Cadence Pharmaceuticals
30-day Free TrialCadence Pharmaceuticals operates in the Life Science industry sector and is a
current portfolio company holding of Bay City Capital Funds
Company Details
Focused on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting. The company? lead product is Acetavance, a patent-protected intravenous (IV) formulati.... more info >
Sign-up for a profile of
Cadence Pharmaceuticals (and more than 25,000 other PE-backed portfolio companies).
Parent Details
Bay City Capital was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay Cit.... more info >
PrivateEquityFirms.com is an easily searchable database of private equity firms, their portfolio companies, and firm personnel. At a glance;
2,000+ Private Equity Firms
26,000+ Portfolio Companies
16,000+ Firm Contacts
Easy to use search tools
Save searches/Create project lists
Export info